Estrogen receptor (ER)
Детермінований перегляд YAML-сутності з джерельної бази. Клінічний авторитет лишається за вказаними source ID та статусом клінічного sign-off.
| ID | BIO-ESTROGEN-RECEPTOR |
|---|---|
| Тип | Біомаркер |
| Синоніми | Estrogen receptorЕстрогеновий рецептор (ЕР) |
| Статус | очікує клінічного підпису |
| Хвороби | Не вказано |
| Джерела | Не вказано |
Дані про біомаркер
| Тип біомаркера | protein_expression_ihc |
|---|---|
| Вимірювання | MethodImmunohistochemistry on FFPE tumor tissue (ASCO/CAP-validated antibody) Unitspercent of tumor nuclei staining Typical range
|
| Пов’язані біомаркери | BIO-PROGESTERONE-RECEPTOR BIO-HER2-SOLID |
Нотатки
Foundational biomarker for breast cancer subtype assignment. Drives endocrine therapy eligibility and CDK4/6i indication. Cross-validated with PR for HR-positive classification.
Де використовується
Indications
IND-BREAST-BRCA-MET-TALAZOPARIB- IND-BREAST-BRCA-MET-TALAZOPARIBIND-BREAST-HER2-LOW-2L-DATO-DXD- IND-BREAST-HER2-LOW-2L-DATO-DXDIND-BREAST-HR-POS-1L-INAVOLISIB- IND-BREAST-HR-POS-1L-INAVOLISIBIND-BREAST-HR-POS-2L-AKT-CAPIVASERTIB- IND-BREAST-HR-POS-2L-AKT-CAPIVASERTIBIND-BREAST-HR-POS-2L-DATO-DXD- IND-BREAST-HR-POS-2L-DATO-DXDIND-BREAST-HR-POS-2L-ESR1-ELACESTRANT- IND-BREAST-HR-POS-2L-ESR1-ELACESTRANTIND-BREAST-HR-POS-2L-FUL-EVEROLIMUS- IND-BREAST-HR-POS-2L-FUL-EVEROLIMUSIND-BREAST-HR-POS-2L-PIK3CA-ALPELISIB- IND-BREAST-HR-POS-2L-PIK3CA-ALPELISIBIND-BREAST-HR-POS-2L-T-DXD-HER2-LOW- IND-BREAST-HR-POS-2L-T-DXD-HER2-LOWIND-BREAST-HR-POS-3L-POST-CDK46I-POST-AKT- IND-BREAST-HR-POS-3L-POST-CDK46I-POST-AKTIND-BREAST-HR-POS-EARLY-ADJ-CDK46I- IND-BREAST-HR-POS-EARLY-ADJ-CDK46IIND-BREAST-HR-POS-EARLY-ADJ-RIBOCICLIB- IND-BREAST-HR-POS-EARLY-ADJ-RIBOCICLIBIND-BREAST-HR-POS-MAINT-CDK46I- IND-BREAST-HR-POS-MAINT-CDK46IIND-BREAST-HR-POS-MET-1L-CDKI- IND-BREAST-HR-POS-MET-1L-CDKIIND-BREAST-TNBC-2L-BRCA-OLAPARIB- IND-BREAST-TNBC-2L-BRCA-OLAPARIBIND-BREAST-TNBC-2L-BRCA-TALAZOPARIB- IND-BREAST-TNBC-2L-BRCA-TALAZOPARIBIND-BREAST-TNBC-2L-DATO-DXD- IND-BREAST-TNBC-2L-DATO-DXDIND-BREAST-TNBC-2L-SACITUZUMAB- IND-BREAST-TNBC-2L-SACITUZUMABIND-BREAST-TNBC-2L-T-DXD-HER2-LOW- IND-BREAST-TNBC-2L-T-DXD-HER2-LOWIND-BREAST-TNBC-3L-POST-SACI-POST-T-DXD- IND-BREAST-TNBC-3L-POST-SACI-POST-T-DXDIND-BREAST-TNBC-EARLY-NEOADJUVANT- IND-BREAST-TNBC-EARLY-NEOADJUVANT
Questionnaires
QUEST-BREAST-1L-STUB- Invasive breast cancer — first line
Tests
TEST-ER-PR-IHC- ER + PR immunohistochemistry on tumor
Біомаркер
BIO-ESR1- ESR1 mutation (ligand-binding domain)BIO-HER2-LOW- HER2-low (breast — IHC 1+ OR IHC 2+ ISH-negative)BIO-HER2-ULTRALOW- HER2-ultralow (breast — IHC > 0 < 1+; faint/incomplete membrane staining ≤10%)BIO-PIK3CA-H1047R- PIK3CA H1047R mutationBIO-PROGESTERONE-RECEPTOR- Progesterone receptor (PR)
Тривожна ознака
RF-BREAST-TNBC- Triple-negative breast cancer (TNBC): estrogen receptor (ER) <1% nuclear staining on IHC...